BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2910522)

  • 1. Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine.
    Diwan BA; Nims RW; Ward JM; Hu H; Lubet RA; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):189-94. PubMed ID: 2910522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
    Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
    Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium, and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine.
    Diwan BA; Rice JM; Ohshima M; Ward JM; Dove LF
    J Natl Cancer Inst; 1985 Feb; 74(2):509-16. PubMed ID: 3856057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.
    Diwan BA; Nims RW; Henneman JR; Ward JM; Lubet RA; Rice JM
    Arch Toxicol; 1992; 66(6):413-22. PubMed ID: 1444806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors.
    Diwan BA; Ohshima M; Rice JM
    Carcinogenesis; 1989 Jan; 10(1):183-8. PubMed ID: 2910521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B.
    Diwan BA; Henneman JR; Rice JM; Nims RW
    Carcinogenesis; 1996 Jan; 17(1):37-43. PubMed ID: 8565134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates.
    Nims RW; Devor DE; Henneman JR; Lubet RA
    Carcinogenesis; 1987 Jan; 8(1):67-71. PubMed ID: 3492311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis by phentoin in male F344/NCr rats at a dose causing maximal induction of CYP2B.
    Diwan BA; Henneman JR; Nims RW
    Int J Toxicol; 2001; 20(2):81-7. PubMed ID: 11354469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of promoting effect of clonazepam on the development of N-nitrosodiethylamine-initiated hepatocellular tumors in mice is correlated with its inability to inhibit cell-to-cell communication in mouse hepatocytes.
    Diwan BA; Lubet RA; Nims RW; Klaunig JE; Weghorst CM; Henneman JR; Ward JM; Rice JM
    Carcinogenesis; 1989 Sep; 10(9):1719-24. PubMed ID: 2766464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine.
    Hiasa Y; Kitahori Y; Ohshima M; Fujita T; Yuasa T; Konishi N; Miyashiro A
    Carcinogenesis; 1982; 3(10):1187-90. PubMed ID: 7172417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids.
    Rice JM; Diwan BA; Hu H; Ward JM; Nims RW; Lubet RA
    Carcinogenesis; 1994 Feb; 15(2):395-402. PubMed ID: 8313534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters.
    Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC
    Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative hyaline droplet nephropathy in male F344/NCr rats induced by sodium barbital and diethylacetylurea, a breakdown product of sodium barbital.
    Kurata Y; Diwan BA; Lehman-McKeeman L; Rice JM; Ward JM
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):224-32. PubMed ID: 7516096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat.
    Nims RW; McClain RM; Manchand PS; Belica PS; Thomas PE; Mellini DW; Utermahlen WE; Lubet RA
    J Pharmacol Exp Ther; 1994 Jul; 270(1):348-55. PubMed ID: 8035330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital.
    Diwan BA; Palmer AE; Ohshima M; Rice JM
    J Natl Cancer Inst; 1985 Dec; 75(6):1099-105. PubMed ID: 3865012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.
    Diwan BA; Anderson LM; Ward JM; Henneman JR; Rice JM
    Toxicol Appl Pharmacol; 1995 May; 132(1):115-21. PubMed ID: 7747274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation by nickel acetate and promotion by sodium barbital of renal cortical epithelial tumors in male F344 rats.
    Kasprzak KS; Diwan BA; Konishi N; Misra M; Rice JM
    Carcinogenesis; 1990 Apr; 11(4):647-52. PubMed ID: 2323003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of renal carcinogens and tumor promoters on growth promotion and inhibition of gap junctional communication in two rat renal epithelial cell lines.
    Konishi N; Donovan PJ; Ward JM
    Carcinogenesis; 1990 Jun; 11(6):903-8. PubMed ID: 2140731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine.
    Diwan BA; Lubet RA; Ward JM; Hrabie JA; Rice JM
    Carcinogenesis; 1992 Oct; 13(10):1893-901. PubMed ID: 1330346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of test methods for examining promoters of hepatocarcinogenesis--promoting effects of phenobarbital, butylated hydroxytoluene and barbital].
    Furukawa F; Toyoda K; Kokubo T; Takahashi M; Hayashi Y
    Eisei Shikenjo Hokoku; 1984; (102):71-6. PubMed ID: 6532509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.